Elicio Therapeutics, Inc.
ELTX
$4.80
$0.040.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.33M | 11.80M | 12.17M | 12.26M | 11.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.99M | 40.90M | 41.33M | 38.18M | 35.75M |
| Operating Income | -44.99M | -40.90M | -41.33M | -38.18M | -35.75M |
| Income Before Tax | -51.90M | -46.84M | -38.66M | -38.99M | -35.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.90 | -46.84 | -38.66 | -38.99 | -35.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.90M | -46.84M | -38.66M | -38.99M | -35.20M |
| EBIT | -44.99M | -40.90M | -41.33M | -38.18M | -35.75M |
| EBITDA | -44.66M | -40.59M | -41.00M | -37.83M | -35.36M |
| EPS Basic | -4.20 | -4.23 | -4.11 | -6.08 | -29.71 |
| Normalized Basic EPS | -2.63 | -2.65 | -2.57 | -3.93 | -18.70 |
| EPS Diluted | -4.20 | -4.23 | -4.11 | -6.08 | -29.71 |
| Normalized Diluted EPS | -2.63 | -2.65 | -2.57 | -3.93 | -18.70 |
| Average Basic Shares Outstanding | 48.79M | 43.68M | 38.48M | 30.09M | 20.14M |
| Average Diluted Shares Outstanding | 48.79M | 43.68M | 38.48M | 30.09M | 20.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |